Serum Institute of INdia
CDSCO seeks more data from SII, says Covovax not yet approved in country of origin
The DCGI office had granted SII permission to manufacture and stock Covovax on May 17
Differential vaccine pricing is right, Centre tells Supreme Court
Government defends move, says it is to incentivise vaccine makers
Covishield to cost Rs 400 a dose for states, Rs 600 for private hospitals
SII will serve 50% of the total production to the GoI vaccination program, and remaining will be for State governments and private hospitals
Centre allows COVID-19 vaccination at places of work from April 11
This change in the government’s plan comes as the desired target for vaccinations is yet to be achieved
DCGI extends shelf life of Covishield from 6 to 9 months
In a letter to the Serum Institute, DCGI said it is permitted to apply the shelf life of nine months to unlabelled vials available on hand
Chinese hackers target Indian vaccine makers
Chinese hacking group APT10, also known as Stone Panda, identified gaps in the IT infra and supply chain software of Bharat Biotech and SII
Covishield to cost Rs.200 per dose, export banned by government
The government is now in a hurry to start vaccination drive, the schedule for which will be announced soon
Covishield moves closer to approval
The recommendation on Covishield has been forwarded to the Drugs Controller General of India, which is likely to take a final call soon
DCGI denies EUA to Covid vaccines shots of Bharat Biotech, Serum
‘Expert panels seeks more data on efficiency, safety’
Serum likely to supply COVID-19 vaccine at over Rs 250 per dose to Indian government
Poonawalla had said Serum will first focus on supplying the vaccine to Indians before distributing it to other countries